RxDoctor Payments Data

Nazli Okumus

Interventional Cardiology · Ocala, FLNPI 1124504014

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,832 of the $16,542 with a category attached, or 65.5%. It is spread thinly across 29 manufacturers, the largest accounting for just 18.4%. 2025 is the largest year on record at $8,071, more than ten times the $453 reported in 2021.

$16,542in general payments, 2019–2025

Across 245 payments — averaging $67.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Abbott$3K
  • W. L. Gore & Associates, Inc.$3K
  • Edwards Lifesciences$2K
  • Abiomed$2K
  • Boston Scientific$684
  • plus $3K from 23 others

What the payments were for

  • Consulting fees$1481%
  • Travel & lodging$4,69328%
  • Food & beverage$10,83265%
  • Education$8685%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,542 in reported general payments places this provider in the 70th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida →

Other interventional cardiology in Ocala

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →